The Glutethimide Market is anticipated to gain exponential industry growth over the given forecast period of 2022-2028.
Glutethimide is a hypnotic sedative that is a safe alternative to barbiturates for the treatment of insomnia. It is mainly used to help patients feel drowsy and calm. Glutethimide is highly lipophilic and is concentrated in adipose tissue and brain. It is an alternative to barbiturates. It undergoes extensive metabolism in the liver, with both unbound and bound metabolites excreted by the kidneys. Glutetimide is a CYP2D6 enzyme inducer and when taken with codeine, the body can convert large amounts of codeine to morphine. The most common brand names for glutethimide are ciba, glue, and gofers. It is classified as a Schedule II drug according to its psychotropic substance. In addition, glutethimide is used to prevent jaundice in newborns and reduce muscle tremors.
(Get 15% Discount on Buying this Report)
A full report of Global Glutethimide Market is available at: https://orionmarketreports.com/glutethimide-market/101129/
Market Segments
By Product Type
- Tablets
- Injection
- Capsules
- Powder
- Herbal Compounds
By Application
- Psychiatric disorders
- Prostatic Hypertrophy
- Cardiac Arrhythmias
Key Players
- Pfizer Inc.
- Abbott Laboratories
- Mankind Pharma
- Glaxosimithkine PLC
- Sanofi S.A
- Novartis
- Agilent Technologies
- Abbvie Inc
- Bristol Mayers Squibb
- Astrazeneca
Scope of the Report
The research study analyzes the global Glutethimide industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:
Recent Developments
o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment
Geographic Coverage
o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume
Key Questions Answered by Glutethimide Market Report
1. What was the Glutethimide Market size in 2020 and 2021; what are the estimated growth trends and market forecast (2022-2028).
2. What will be the CAGR of Glutethimide Market during the forecast period (2022-2028)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2022? How these segments are expected to grow during the forecast period (2022-2028).
4. Which manufacturer/vendor/players in the Glutethimide Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.
The report covers the following objectives:
- Proliferation and maturation of trade in the global Glutethimide market.
- The market share of the global Glutethimide market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
- Current and future market trends that are influencing the growth opportunities and growth rate of the global Glutethimide market.
- Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Glutethimide market.
About Us:
Orion Market Reports (OMR) endeavors to provide an exclusive blend of qualitative and quantitative market research reports to clients across the globe. Our organization helps both multinational and domestic enterprises to bolster their business by providing in-depth market insights and the most reliable future market trends. Our reports address all the major aspects of the markets providing insights and market outlook to global clients.
Media Contact:
Company Name: Orion Market Reports
Contact Person: Mr. Anurag Tiwari
Email: info@orionmarketreports.com
Contact no: +91 780-304-0404
